10-Q/A XBRL

10-Q/A Filing

Company: Travere Therapeutics, Inc.
Filed: September 16, 2013
Period of Report: March 31, 2013
Accession Number: 0001193805-13-001601

View Document ↗ View on SEC.gov ↗